Citation Impact
Citing Papers
Allogeneic Granulocyte Macrophage Colony-Stimulating Factor–Secreting Tumor Immunotherapy Alone or in Sequence with Cyclophosphamide for Metastatic Pancreatic Cancer: A Pilot Study of Safety, Feasibility, and Immune Activation
2008
Systemic Delivery of Microencapsulated 3-Bromopyruvate for the Therapy of Pancreatic Cancer
2014 StandoutNobel
Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
2008 Standout
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
2009 StandoutNobel
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
2007 Standout
The integration of cytotoxics and biologicals in the treatment of metastatic colorectal cancer
2007
EGFR Antagonists in Cancer Treatment
2008 Standout
Pancreatic cancer
2004 Standout
Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma
2012 Standout
Epithelial-Mesenchymal Transitions in Development and Disease
2009 Standout
Quantitative PET of EGFR expression in xenograft-bearing mice using 64Cu-labeled cetuximab, a chimeric anti-EGFR monoclonal antibody
2007
Lung Cancer
2008 Standout
Advanced pancreatic carcinoma: current treatment and future challenges
2010
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
2010 StandoutNature
Pancreatic cancer
2016 Standout
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
2009 Standout
Macrolides sensitize EGFR-TKI-induced non-apoptotic cell death via blocking autophagy flux in pancreatic cancer cell lines
2015 StandoutNobel
Pancreatic Adenocarcinoma
2014 Standout
A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease
2019
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Review of the Apoptosis Pathways in Pancreatic Cancer and the Anti‐apoptotic Effects of the Novel Sea Cucumber Compound, Frondoside A
2008
Taking dendritic cells into medicine
2007 StandoutNatureNobel
Multi-targeted therapy of cancer by genistein
2008 Standout
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
2007 Standout
Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer
2007 Standout
The tumor microenvironment and its role in promoting tumor growth
2008 Standout
Pancreatic Cancer
2010 Standout
Design of amyloidogenic peptide traps
2024 StandoutNobel
Anti-epidermal growth factor receptor monoclonal antibodies in cancer treatment
2009
Predicting response to epidermal growth factor receptor-targeted therapy in colorectal cancer
2007
Andrographolide and its analogues: versatile bioactive molecules for combating inflammation and cancer
2011 Standout
Withaferin A targets heat shock protein 90 in pancreatic cancer cells
2009
Immunotherapy for pancreatic cancer — science driving clinical progress
2005
Pancreatic cancer
2011 Standout
The Human Cancer Antigen Mesothelin Is More Efficiently Presented to the Mouse Immune System when Targeted to the DEC‐205/CD205 Receptor on Dendritic Cells
2009 StandoutNobel
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
2015 Standout
A Phase II Study of Gefitinib in Patients with Advanced Thyroid Cancer
2007
Molecular Evidence for Increased Antitumor Activity of Gemcitabine by Genistein In vitro and In vivo Using an Orthotopic Model of Pancreatic Cancer
2005
General principles of tumor immunotherapy : basic and clinical applications of tumor immunology
2007
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Therapeutic Synergy of Oral Taxane BMS-275183 and Cetuximab versus Human Tumor Xenografts
2004
Synergistic Antipancreatic Tumor Effect by Simultaneously Targeting Hypoxic Cancer Cells With HSP90 Inhibitor and Glycolysis Inhibitor
2008
Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study Group
2006 Standout
Oxidative Stress, Prooxidants, and Antioxidants: The Interplay
2014 Standout
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
2011 Standout
High-Value Components and Bioactives from Sea Cucumbers for Functional Foods—A Review
2011 Standout
Molecular correlates of gefitinib responsiveness in human bladder cancer cells
2007
Gemcitabine in Combination With Oxaliplatin Compared With Gemcitabine Alone in Locally Advanced or Metastatic Pancreatic Cancer: Results of a GERCOR and GISCAD Phase III Trial
2005
Flavonoids in Cancer and Apoptosis
2018 Standout
Management of Advanced Pancreatic Cancer with Gemcitabine Plus Erlotinib: Efficacy and Safety Results in Clinical Practice
2013
Metastatic pancreatic cancer: Is gemcitabine still the best standard treatment? (Review)
2010
Pancreatic Adenocarcinoma Clinical Practice Guidelines in Oncology
2005
Works of William Schmidt being referenced
RESULTS FROM A PHASE II STUDY TO ASSESS THE CLINICAL AND IMMUNOLOGICAL ACTIVITY OF AFFITOPE® AD02 IN PATIENTS WITH EARLY ALZHEIMER’S DISEASE
2015
Cetuximab, a Monoclonal Antibody Targeting the Epidermal Growth Factor Receptor, in Combination With Gemcitabine for Advanced Pancreatic Cancer: A Multicenter Phase II Trial
2004